|
Volumn 40, Issue 6, 2003, Pages
|
Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes.
a a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ASPARAGINE;
LYSINE;
MUSCLE PROTEIN;
NICOTINIC RECEPTOR;
PERIPHERAL MEMBRANE PROTEIN 43K;
ADULT;
AMINO ACID SUBSTITUTION;
ARTICLE;
CHILD;
CLINICAL TRIAL;
CONGENITAL MYASTHENIC SYNDROME;
FEMALE;
FOUNDER EFFECT;
GENETICS;
HUMAN;
INFANT;
MALE;
MULTICENTER STUDY;
MUTATION;
PEDIGREE;
PRESCHOOL CHILD;
ADULT;
AMINO ACID SUBSTITUTION;
ASPARAGINE;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
FOUNDER EFFECT;
HUMANS;
INFANT;
LYSINE;
MALE;
MUSCLE PROTEINS;
MUTATION;
MYASTHENIC SYNDROMES, CONGENITAL;
PEDIGREE;
RECEPTORS, NICOTINIC;
|
EID: 0037805256
PISSN: None
EISSN: 14686244
Source Type: Journal
DOI: 10.1136/jmg.40.6.e81 Document Type: Article |
Times cited : (48)
|
References (0)
|